Teneligliptin(MP-513) Versus Placebo in Type 2 Diabetes Mellitus

Clinical trial NCT01798238 · COMPLETED

Trial details

NCT number: NCT01798238
Sponsor: Handok Inc.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Type 2 Diabetes Mellitus

Start date: 2012-11-01
Primary completion: 2014-05-01
Enrollment: 142

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.